J&J snaps of Abbott’s eye unit for $4.36bn
Johnson & Johnson is buying Abbott’s eye health unit in a cash deal worth $4.36 billion, building on its presence in the area and marking its entry into cataract surgery.
Read More
Tag: cataracts
Cataract operations being rationed, warns RNIB
The Royal National Institute for the Blind claims that its research continues to show cataract operations are being restricted due to financial pressures on the NHS.
Read More
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
